Autoimmune disease is the immune system attacking the body it’s supposed to defend. Conventional care manages flares with broad immunosuppression. Regenerative medicine asks a different question: can the immune system itself be brought back into balance, rather than turned down?
By Jed Ryan, Founder and CEO · Reviewed by Adas Darinskas, PhD, Chief Science Officer · Published · Last reviewed
Autoimmune conditions arise when the immune system loses its tolerance for self — the trained recognition that distinguishes “your own tissue” from “foreign threat.” The trigger varies (genetic predisposition, viral infection, chronic inflammation, gut dysbiosis), but the downstream pattern is consistent: regulatory mechanisms fail, autoreactive T and B cells go un-checked, and tissue takes the damage.
We work with the following conditions in this cluster:
Each presents differently, but the underlying immunology shares enough common ground that the regenerative approach is largely the same. The goal isn’t suppression — it’s recalibration.
Whatever the autoimmune diagnosis, four interlocking systems tend to be misfiring at the same time. A useful protocol targets all of them.
Conventional immunosuppressants (steroids, biologics, JAK inhibitors) blunt the first system effectively but do nothing for the others — and broad suppression carries its own infection and malignancy risks over time. Regenerative approaches target the underlying balance instead.
Immunotherapy is bidirectional. The same cellular tools used to stimulate a sluggish immune response in oncology can be used to recalibrate an overactive one in autoimmunity. The mechanism is shared: instructive signaling that nudges the immune system back toward balance.
None of this is framed as a cure. The framing is biological: a recalibrated immune system damages less tissue, requires less suppression, and gives the body room to heal what’s already been hit.
Each protocol is designed individually by Dr. Adas Darinskas based on the specific autoimmune diagnosis, severity, and treatment history. The four building blocks below are the ones most often deployed.
An advanced class of mesenchymal stem cells with a stress-enduring property — they survive the inflammatory environments of active autoimmune disease, where conventional MSCs often die before they can work. Their immunomodulatory action runs through IDO and PGE2 pathways, regulatory T-cell expansion, and cytokine rebalancing. Delivered systemically by IV.
Learn moreStem-cell-derived nanoparticles that carry the same immunomodulatory cargo as the cells themselves — cytokines, microRNAs, growth factors — without the cellular component. Often layered with cellular therapy in protocols where wider systemic distribution and easier dosing matter.
Learn moreThymosin Alpha-1 supports T-cell maturation and balance. KPV is a tripeptide with potent anti-inflammatory effects, particularly useful in inflammatory bowel disease. BPC-157 supports gut barrier integrity — addressing the gut permeability that triggers and perpetuates many autoimmune conditions. Run as defined-duration cycles after the in-clinic cellular work.
Learn moreHigh-dose vitamin C, glutathione, NAD+, and amino-acid infusions support the metabolic environment in which immune recalibration has to happen. Particularly relevant in autoimmunity, where chronic oxidative stress is a consistent driver of tissue damage.
Learn moreFor most autoimmune cases the protocol layers these — systemic MSC IV paired with exosomes, peptide cycles continuing at home, and metabolic IVs supporting the days that matter most. None of it is generic. It’s designed to your case and your immune profile.
Strong Craft Regen maintains a continuously updated repository of peer-reviewed research on regenerative medicine — the studies, mechanisms, and ongoing investigations that inform every protocol we coordinate.
Explore the research →